TLR7/8 agonist 9 (Compound 25a), with EC50 values of 40 nM for hTLR7 and 23 nM for hTLR8, demonstrates anti-tumor properties and enhances the efficacy of PD-1/PD-L1 blockade treatments, making it valuable for cancer immunotherapy research [1].
Molecular Weight:
366.46
CAS Number:
[2649170-17-0]
Formula:
C20H26N6O
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted
